financetom
Business
financetom
/
Business
/
Laurentian Bank Logs Q2 Adjusted Profit Beat, but Swings to Net Loss Following Hit From Restructuring and Impairment Charges
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Laurentian Bank Logs Q2 Adjusted Profit Beat, but Swings to Net Loss Following Hit From Restructuring and Impairment Charges
May 31, 2024 5:05 AM

07:36 AM EDT, 05/31/2024 (MT Newswires) -- Laurentian Bank of Canada ( LRCDF ) which is trading near 52-week lows, on Friday reported an adjusted profit beat for its second quarter, but swung to a net loss after taking a hit for restructuring and impairment charges.

Adjusted profit, which excludes most one-time items, was $40.5 million or $0.90 per adjusted share, down from the $51.7 million and $1.16 last year. The result topped the consensus analyst forecast of $0.87 per share, according to Capital IQ. The net loss was $117.5 million, or $2.71 per diluted share, compared with net income of $49.3 million and $1.11 per share, last year.

Reported results included impairment and restructuring charges of $196.8 million ($155.6 million net), or $3.56 per share, the bank said. These were related to the restructuring of its operations and to the impairment of the personal and commercial banking segment.

Total revenue fell to $252.6 million, from $257.2 million for the prior year quarter. Provisions for credit losses climbed to $17.9 million, from $16.2 million for the prior year period, due to higher provisions on impaired loans from credit migration, partly offset by a release of provisions on performing loans.

Laurentian reported that return on common shareholders' equity was a negative 18.6%, compared with 7.7% last year.

The bank maintained a regular quarterly dividend of $0.47 per share, payable on August 1.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Target Likely to Report Weak Q1, Outlook, Morgan Stanley Says
Target Likely to Report Weak Q1, Outlook, Morgan Stanley Says
May 26, 2025
12:06 PM EDT, 05/13/2025 (MT Newswires) -- Target ( TGT ) is likely to report a weak Q1 and guidance amid undemanding valuation, Morgan Stanley said in a Monday note. While 1Q25e comps have likely slowed, and '25e guidance is due for revision, undemanding valuation should limit near-term downside, the report said. It said a widening in valuation discount of...
Update: Paramount Resources Surges Nearly 7% as Q1 Earnings Jump; 2025 Capital Expenditures Guidance Boosted
Update: Paramount Resources Surges Nearly 7% as Q1 Earnings Jump; 2025 Capital Expenditures Guidance Boosted
May 26, 2025
12:07 PM EDT, 05/13/2025 (MT Newswires) -- (Updates shares.) Paramount Resources ( PRMRF ) on Tuesday said its profit surged in the first quarter and revised its 2025 capital expenditures guidance due to work at the Sinclair operation in Alberta. The Western Canadian oil and gas producer said it earned of $1.29 billion, or $8.74 per share in the quarter,...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Medical Technology Firms Face Price Target Revisions From Morgan Stanley
Medical Technology Firms Face Price Target Revisions From Morgan Stanley
May 26, 2025
12:10 PM EDT, 05/13/2025 (MT Newswires) -- Morgan Stanley has revised the price targets of a number of medical technology firms in a Tuesday note. RxSight ( RXST ) has observed a challenging spending environment for its target demographic of adults in the 65-75 age range, Morgan Stanley analysts said, adding that patients are deferring procedures and opting for lower-cost...
Copyright 2023-2026 - www.financetom.com All Rights Reserved